KORU Medical Systems, Inc.

NASDAQ:KRMD

Medical - Instruments & Supplies

Healthcare
$3.45 +1.55%

+$0.06 today

Market cap
$149.64M
Beta
0.42
P/E (TTM)
-80.2
EPS (TTM)
-$0.05
52W Low $2.91High $6.61

Volume 0.19M

Average 0.13M

KRMD Accounts Payables

Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.

KORU Medical Systems, Inc.NASDAQ: KRMD

Accounts Payables · Q1 FY2026 · quarter ended Mar 2026

Accounts payables outflow grows to $368.23K

Q1 FY2026 accounts payables was $368.23K, compared with $0 a year earlier. Trailing-twelve-month accounts payables was $1.54M. Over 3 fiscal years it compounded at -19.1% a year.

Context

  • Accounts payables amounted to 1.5% of revenue in FY2025, down 0.5 pp from a year earlier.
  • Accounts payables increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly accounts payables holds near $368.23K or moves back toward the trailing-twelve-month quarterly average of $385.29K.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$368.23K-6.9% QoQ
Last fiscal yearDec 2025
$617.5K-8.5% YoY
LTMMar 2026
$1.54M+875.1% YoY
Accounts Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year-8.5%——
3-year CAGR-19.1%——
5-year CAGR——
10-year CAGR——

Accounts Payables history

USD · from the cash flow

Latest · FY2025
617.5K USD
Year-over-year change
-8.5%
4-year CAGR
+0.6%

Accounts Payables vs competitors

How KRMD compares with its peers on the latest reported figures

  • Peers report in different currencies, so accounts payables is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +875.1% is the highest of 8, against a peer median of +114.4%.
  • Accounts payables amounts to 3.6% of revenue for KRMD, versus a peer median of 2.8%.
KRMD Competitors
Accounts Payables for KRMD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
PREPrenetics Global LimitedLTM Mar 2026$3.73M USD——3.3%
OSUROraSure Technologies, Inc.LTM Mar 2026$3.11M USD+137.8%—2.8%
NYXHNyxoah S.A.LTM Mar 2026€2.84M EUR——17.4%
INFUInfuSystem Holdings, Inc.LTM Mar 2026$2.46M USD+114.4%—1.7%
TLSITriSalus Life Sciences, Inc.LTM Mar 2026$2.37M USD+45.7%-27.2%5.3%
MXCTMaxCyte, Inc.LTM Mar 2026$1.77M USD-57.7%+191.8%5.5%
KRMDKORU Medical Systems, Inc.LTM Mar 2026$1.54M USD+875.1%-19.1%3.6%
STIMNeuronetics, Inc.LTM Mar 2026$1.45M USD+154.8%-3.8%1.0%
PROFProfound Medical Corp.LTM Mar 2026$387.3K USD-77.1%—2.1%
UTMDUtah Medical Products, Inc.LTM Mar 2026$278K USD+423.3%-23.1%0.7%
Peer median (excluding KRMD) —+114.4%-13.5%2.8%

Competitors are the stored peer set for KRMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(4.56M)(8.66M)(13.74M)(6.07M)(2.64M)
Depreciation & Amortization463.13K587.14K870.39K888.47K810.5K
Deferred Income Tax(1.82M)(2.03M)3.97M00
Stock-Based Compensation2.71M3.08M2.77M2.62M2.71M
Change in Working Capital(1.11M)1.4M1.2M1.97M(319.17K)
Accounts Receivables(1.74M)(220.17K)457.18K(1.68M)(489.2K)
Inventory723.43K(298.53K)2.92M677.63K(874.46K)
Accounts Payables602.61K1.16M(1.42M)674.78K617.5K
Other Working Capital(698.28K)758.15K(760.19K)2.3M426.99K
Other Non-Cash Items(1.01K)212.55K37.82K259.55K(104.54K)
Operating Cash Flow(4.32M)(5.4M)(4.89M)(319.72K)462.41K
Capital Expenditures(375.23K)(2.8M)(814.6K)(1.3M)(932.52K)
Acquisitions (Net)00000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(19.99K)(40.51K)(31.65K)(35.62K)(17.27K)
Investing Cash Flow(366.17K)(2.8M)(814.6K)(1.33M)(949.79K)
Debt Repayment505.94K(127.14K)(218.87K)(107.96K)(379.98K)
Common Stock Issued2.2M406.62K00186.17K
Common Stock Repurchased000(97.38K)0
Dividends Paid00000
Other Financing Activities000(43.19K)(27.54K)
Financing Cash Flow2.71M279.49K(218.87K)(248.53K)(221.35K)
Effect of Forex Changes00000
Net Change in Cash(1.98M)(7.93M)(5.93M)(1.9M)(708.74K)
Free Cash Flow(4.69M)(8.21M)(5.71M)(1.62M)(470.11K)

KORU Medical Systems, Inc.

NASDAQ:KRMD

Intrinsic Alpha fair value

Locked

Current Price

$3.45

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.